Research & Development
23 September 2021 - The European Medicines Agency (EMA), the EU's drug regulator, is expected to decide in early October on the possible use of a booster dose of the Pfizer (NYSE:PFE)/BioNTech (N...
23 September 2021 - Healthcare company Pfizer Inc (NYSE:PFE) and BioNTech SE (Nasdaq:BNTX) reported on Wednesday the receipt of the US Food and Drug Administration's (FDA) emergency use for the b...
23 September 2021 - The US Food and Drug Administration (FDA) has authorised a booster dose of the Pfizer Inc (NYSE:PFE)/BioNTech (Nasdaq:BNTX) COVID-19 vaccine for those aged 65 and older, all people...
22 September 2021 - - The US Food and Drug Administration has approved Jakafi (ruxolitinib) for treatment of chronic graft-versus-host disease after failure of one or two lines of systemic therap...
22 September 2021 - - US-based pharmaceutical company Pfizer Inc. (NYSE: PFE) and German biotechnology company BioNTech SE (NASDAQ: BNTX) plan to expand their agreement with the US government by provi...
22 September 2021 - - French biopharmaceutical company Poxel SA (Euronext POXEL - FR0012432516) has completed enrollment in DESTINY-1 (Deuterium-stabilized R-pioglitazone (PXL065) Efficacy and Sa...
Related Headlines